Why the study?
Does acute sildenafil intake improve ergoreflex, endothelial function, and exercise ventilation in chronic heart failure patients?
Does acute sildenafil intake improve ergoreflex, endothelial function, and exercise ventilation in chronic heart failure patients?
Acute sildenafil administration improves endothelial function, modulates ergoreflex signaling, and enhances ventilatory and aerobic efficiency in patients with chronic heart failure.
Acute sildenafil attenuated ergoreflex in HF; leaves open whether chronic PDE5 inhibition improves exercise capacity or symptoms.
Reflex neural oversignaling sensitive to muscle by-products (ergoreflex) causes exercise hyperventilation in heart failure (HF). We probed whether an improved endothelial function with sildenafil intake may prevent this effect. In 16 chronic heart failure patients and 16 normal subjects, before and after sildenafil intake (50 mg) or placebo, we measured ergoreflex, flow-mediated brachial artery dilation (FMD, an index of endothelial function), and, during maximal exercise, the slope of ventilation to carbon dioxide production (VE/VCO2, an index of ventilatory efficiency), the ratio of changes in O2 uptake (VO2) versus work rate (WR) (deltaVO2/deltaWR, an index of aerobic efficiency). After sildenafil intake, patients, unlike controls, showed a significant decrease in ergoreflex and VE/VCO2 slope and an increase in FMD and deltaVO2/deltaWR. Ergoreflex changes with sildenafil intake correlated with those in FMD and VE/VCO2. Phosphodiesterase-5 inhibition, by improving endothelial activity and muscle perfusion, modulates signaling and improves ventilatory and aerobic efficiencies, potentially indicating a novel pathway in the HF therapeutic management.
No takes yet. Share an insight, caveat, or question.
Guazzi et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: